Answer
The press release you referenced – “Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results” (published August 7 2025 by Business Wire) – does not contain the specific financial numbers in the excerpt you provided. Consequently, the actual Q2 2025 revenue and earnings figures, as well as the analysts’ consensus expectations for those metrics, cannot be extracted from the information given.
What you would need to determine the answer
Full press‑release or earnings filing – The complete Amylyx Pharmaceuticals Q2 2025 earnings announcement (usually posted on the company’s investor‑relations website or on the SEC’s EDGAR system) will list:
- Revenue for the quarter (e.g., “Revenue was $X million”).
- Net earnings (or loss) for the quarter (e.g., “Net earnings were $Y million” or “Net loss was $Y million”).
Analyst consensus estimates – These are typically compiled by financial‑data providers such as FactSet, Bloomberg, Thomson Reuters, or S&P Capital IQ. The consensus numbers for Q2 2025 would include:
- Expected revenue (e.g., “Analysts expected $A million”).
- Expected earnings (or EPS) (e.g., “Analysts expected earnings of $B per share”).
Comparison – Once you have both sets of numbers, you can calculate the variance:
- Revenue variance = Actual revenue – Expected revenue (and optionally express it as a percentage).
- Earnings variance = Actual earnings (or loss) – Expected earnings (or EPS) (and optionally express it as a percentage).
Typical format for a comprehensive answer (once the data are available)
| Metric | Actual Q2 2025 | Analysts’ Expectation | Variance (Δ) | % Variance |
|---|---|---|---|---|
| Revenue | $X million | $A million | $X – $A | ((X‑A)/A) × 100% |
| Net earnings (loss) | $Y million (or $Y per share) | $B million (or $B per share) | $Y – $B | ((Y‑B)/B) × 100% |
Next steps for you
- Locate the full Amylyx Q2 2025 earnings release (e.g., on Amylyx’s investor‑relations page or the SEC’s Form 10‑Q filing for the quarter ending June 30 2025).
- Retrieve the consensus analyst estimates for Q2 2025 from a financial‑data platform (FactSet, Bloomberg, Thomson Reuters, etc.) or from a brokerage research note that covered the release.
- Plug those numbers into the table above to see exactly how Amylyx’s actual performance compared to market expectations.
If you can provide the complete earnings release or the analyst consensus numbers, I can immediately calculate the variances and give you a detailed, data‑driven comparison.